To be able to interpret metabolic differences between AML and healthy CD34+ cells we compared our quantitative proteome data with transcriptome data generated by us34 and others3,35, specifically focusing on glycolysis, the TCA cycle and glutaminolysis (Fig. 1e, f). This evidence concerns the gene CD34 and acute myeloid leukemia.